- Home
- » Tags
- » Levetiracetam
Top View
- Chapter 26 Starting Antiepileptic Drug Treatment
- APTIOM (Eslicarbazepine Acetate) Tablets, for Oral Use • Withdrawal of APTIOM: Withdraw APTIOM Gradually to Minimize the Initial U.S
- Study Protocol SEP093-701
- Levetiracetam Induces a Rapid and Sustained Reduction of Generalized Spike-Wave and Clinical Absence
- Prescribing Information
- Seizure Outcome After Switching Antiepileptic Drugs: a Matched, Prospective Study
- Levetiracetam (Keppra®)
- The Safety of Medications Used to Treat
- The New Antiepileptic Drugs Scientific Review
- Keppra, INN-Levetiracetam
- MEDICATION GUIDE Levetiracetam Tablets 250 Mg, 500 Mg and 750
- Risk of Ischaemic Stroke Associated with Antiepileptic Drugs
- Levetiracetam Versus Phenytoin for Second-Line Treatment of Convulsive
- MEDICATION GUIDE Levetiracetam Tablets 250 Mg, 500 Mg, 750 Mg, 1000 Mg Read This Medication Guide Before You Start Taking Levetiractem and Each Time You Get a Refill
- 2-Pyrrolidinone and Succinimide As Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-Seizure Medications Impact Accurate Diagnosis
- Long-Term Observational Study of Eslicarbazepine Acetate Monotherapy
- Efficacy and Safety of Conversion to Monotherapy with Eslicarbazepine
- Antiepileptics – Levetiracetam, Brivaracetam
- Efficacy and Safety of Eslicarbazepine Acetate Monotherapy in Patients Converting from Carbamazepine
- Eslicarbazepine Acetate (Esl)
- Pearls and Pitfalls of Introducing Ketogenic Diet in Adult Status Epilepticus: a Practical Guide for the Intensivist
- Diapositiva 1
- Labeled Amount of Levetiracetam
- Appendix A. Table A1. Pharmacological Classes for Migraine Prevention
- Antiepileptika (ATC-Code: N03 *)
- KEPPRA Safely and Effectively
- Levetiracetam) Rx Only 250 Mg, 500 Mg and 750 Mg Tablets 100 Mg/Ml Oral Solution
- Conversion to Eslicarbazepine Acetate Monotherapy a Pooled Analysis of 2 Phase III Studies
- LAMICTAL Safely and Effectively
- What Is Levetiracetam?
- BRIVIACT® Safely and Effectively
- Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders
- Anticonvulsants
- KEPPRA (Levetiracetam) 500 Mg/5 Ml Injection Is a Baseline Period Is Referred to As “Baseline” in the Clear, Colorless, Sterile Solution
- 2.3 Myoclonic Seizures in Patients 12 Years of Age and Older With
- Advances in Current Medication and New Therapeutic Approaches in Epilepsy
- Effect of Levetiracetam on Penicillin Induced Epileptic Activity in Rats
- Antiepileptic Drug Therapy in Patients with Autoimmune Epilepsy
- Anticonvulsant Medications: U.S. Food and Drug Administration-Approved Indications and Dosages for Use in Pediatric Patients
- Divergent Interaction Profiles of Gabapentin and Levetiracetam With
- Efficacy and Tolerability of the New Antiepileptic Drugs I: Treatment Of
- An Audit of Lamotrigine, Levetiracetam and Topiramate Usage for Epilepsy in a District General Hospital
- Levetiracetam and Brivaracetam: Synthesis of Radioligands As
- The Integrated Effects of Brivaracetam, a Selective Analog of Levetiracetam, on Ionic Currents and Neuronal Excitability
- Levetiracetam-Hospira-Epar-Product
- Comparison of Phenytoin, Valproate and Levetiracetam in Pediatric Convulsive Status Epilepticus: a Randomized Double-Blind Controlled Clinical Trial
- Α Multicenter Retrospective Study Evaluating Brivaracetam in The
- Frequently Identified Genetic Developmental and Epileptic Encephalopathy: a Review Focusing on Precision Medicine
- The Treatment of Super-Refractory Status Epilepticus: a Critical Review of Available Therapies and a Clinical Treatment Protocol
- Anticonvulsant Medications: U.S. Food and Drug Administration-Approved Indications and Most Common Dosages for Use in Adults